PLCD3: Phospholipase C Delta 3

A key enzyme in phosphoinositide signaling, implicated in cancer and developmental disorders

Gene Information Card

Symbol PLCD3
Full Name Phospholipase C Delta 3
Gene Type protein-coding
Chromosomal Location 17q21.31
NCBI Gene ID 113026 ncbi.nlm.nih.gov/gene/113026
Ensembl ID ENSG00000108379
UniProt ID Q8N3E9
OMIM ID 608795
HGNC ID 17884
Aliases PLC-delta-3, PLC-delta3

Description

PLCD3 encodes phospholipase C delta 3, an enzyme that hydrolyzes phosphatidylinositol 4,5-bisphosphate to generate second messengers inositol 1,4,5-trisphosphate (IP3) and diacylglycerol (DAG). It is involved in calcium signaling, cell proliferation, and differentiation. Mutations and altered expression are linked to various cancers and developmental disorders.

Disease Associations

Disease category Pathophysiological mechanism Genomic evidence
Hepatocellular carcinoma Overexpression of PLCD3 promotes cell proliferation and migration via PI3K/AKT pathway activation PMID: 31467435
Colorectal cancer PLCD3 upregulation correlates with poor prognosis and increased metastasis PMID: 30523347
Esophageal squamous cell carcinoma PLCD3 amplification and overexpression drive tumor growth PMID: 27197152
Developmental and epileptic encephalopathy Homozygous missense mutations impair enzyme activity leading to neuronal dysfunction ClinVar: RCV000626014

Expression Profile

Tissue Expression
Tissue nTPM level
Brain 12.5 Medium
Liver 8.3 Low
Kidney 15.1 Medium
Testis 22.4 High
Lung 6.7 Low
Cell Line Expression
Cell Line nTPM Notes
HEK293 18.9 High expression
HepG2 14.2 Medium expression
A549 9.8 Low expression
MCF7 11.5 Medium expression
Data source:Human Protein Atlas(proteinatlas.org)

Mutations & Variants

Hotspot Mutations
Variant Type Frequency Functional Description
c.1243G>A (p.Gly415Arg) Missense 0.001% Reduced catalytic activity; associated with developmental encephalopathy (ClinVar)
c.1765C>T (p.Arg589Trp) Missense 0.002% Loss of function; reported in epilepsy (ClinVar)
c.2023_2024insA (p.Thr675Asnfs*2) Frameshift <0.001% Truncated protein; loss of function (COSMIC)
Mutation functional classification

Loss of Function (LOF)

Missense and frameshift mutations (e.g., p.Gly415Arg, p.Arg589Trp) reduce or abolish phospholipase activity, impairing IP3/DAG signaling.

Gain of Function (GOF)

Not well documented; overexpression in cancers may act as a functional gain but no activating mutations reported.

Dominant Negative (DN)

No dominant-negative mutations currently described in literature or databases.

Gene Ontology (GO)

• phospholipase C activity • calcium ion binding
• phosphatidylinositol phospholipase C activity • signal transduction
• inositol phosphate metabolic process • cell proliferation
• plasma membrane

Pathways

Phospholipase C signaling pathway
Calcium signaling pathway
PI3K-Akt signaling pathway
Inositol phosphate metabolism

Protein Summary

PLCD3 is a 789-amino acid protein belonging to the phospholipase C delta family. It contains pleckstrin homology (PH) domain, EF-hand domain, catalytic TIM barrel domain, and C2 domain. The enzyme is activated by calcium and G-protein subunits, and it localizes to the plasma membrane. It plays a critical role in generating second messengers for cellular signaling.

Related Products

Product name Cat.No. Species Gene ID
PLCD3 Knockout HEK293 Cell Line EDJ-KQ1616 Human 113026 Details Get a Quote
PLCD3 Knockout HeLa Cell Line EDJ-KQ19962 Human 113026 Details Get a Quote
PLCD3 Knockout A-549 Cell Line EDJ-KQ21309 Human 113026 Details Get a Quote
PLCD3 Knockout HCT 116 Cell Line EDJ-KQ21310 Human 113026 Details Get a Quote
PLCD3 Knockout HAP1 Cell Line EDC08128 Human 113026 Details Get a Quote
Displaying Records 1 To 5 Of 5 Records
Contact Us
*
*
*
*
How did you hear about us: